Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer [Yahoo! Finance]
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer
Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Compass Therapeutics, Inc. (NASDAQ: CMPX) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.